|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$99,220.14 |
3.14% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$93,924.01 |
2.97% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$92,601.01 |
2.93% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$89,882.73 |
2.84% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$86,023.85 |
2.72% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$82,502.88 |
2.61% |
| Waters Corporation |
WAT |
941848103 |
184 |
$81,500.96 |
2.58% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$80,829.09 |
2.56% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$80,074.80 |
2.53% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$79,692.59 |
2.52% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$79,832.28 |
2.52% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$77,502.28 |
2.45% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$76,622.59 |
2.42% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$75,168.00 |
2.38% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$72,631.67 |
2.30% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$72,577.40 |
2.29% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$70,472.30 |
2.23% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$70,223.06 |
2.22% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$69,536.70 |
2.20% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$69,295.61 |
2.19% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$67,266.27 |
2.13% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$65,730.31 |
2.08% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$64,863.70 |
2.05% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$63,984.23 |
2.02% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$63,435.24 |
2.01% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$60,502.00 |
1.91% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$59,376.24 |
1.88% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$58,549.59 |
1.85% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$57,995.46 |
1.83% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$57,301.80 |
1.81% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,814.04 |
1.80% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$56,114.77 |
1.77% |
| Steris Plc |
STE |
G8473T100 |
265 |
$55,915.00 |
1.77% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$53,891.46 |
1.70% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$53,922.70 |
1.70% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$51,769.60 |
1.64% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$50,551.95 |
1.60% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$49,300.00 |
1.56% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$49,299.87 |
1.56% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$48,722.01 |
1.54% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$48,756.56 |
1.54% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$47,903.94 |
1.51% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$47,178.56 |
1.49% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$46,839.96 |
1.48% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,545.14 |
1.41% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$44,055.64 |
1.39% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$42,322.76 |
1.34% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$42,125.05 |
1.33% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$39,933.00 |
1.26% |
| US Dollar |
$USD |
|
13,418 |
$13,417.77 |
0.42% |
| Australian Dollar |
$AUD |
|
601 |
$421.58 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|